BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Retina
,
DNA fingerprint
,
Cisplatin
,
rs3825942
,
ERBB2
,
Fatty acid metabolic process
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
ovarian sarcomas
(biogroup)
Summary
General Info
Body Atlas
Most Correlated Tissues
Bladder
Thyroid gland
Ovary
Adrenal gland cortex
Thalamus lateral nuclei
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Abscess
Epstein-Barr virus disease
Hemorrhagic shock
Viral enteritis
Injury of liver
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
2-ethoxy-3-(4-((4-(methylsulfonyloxy)phenethyl)oxy)phenyl)propanoic acid
aleglitazar
roscovitine
Poliovirus Vaccines
Thyroxine
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
ESCO1
MAP3K7
RABGGTA
HPS1
SOD2
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
L1000 CMAP - Breast adenocarcinoma SKBR3 cells treated with small molecule perturbagens
L1000 CMAP - Bone marrow CD34 cells treated with small molecule perturbagens
L1000 CMAP - Colorectal cancer HT29 cells treated with ligand perturbagens
L1000 CMAP - Neuronal NEU cells treated with small molecule perturbagens
L1000 CMAP - Motor neuron MNEU.E cells treated with small molecule perturbagens
Explore Curated Studies Results
Literature
Most Relevant Literature
There were no matches for ovarian sarcomas
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Trabectedin Combined With Durvalumab in Patients With Advanced Pretreated Soft-tissue Sarcomas and O…
A Dose Escalation Study Of PF-06801591 In Melanoma, Head And Neck Cancer (SCCHN), Ovarian, Sarcoma, …
LN-145 or LN-145-S1 in Treating Patients With Relapsed or Refractory Ovarian Cancer, Triple Negative…
Chemotherapy in Treating Patients With Advanced Sarcoma
Combination Chemotherapy in Treating Patients With Sarcoma
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ